Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-004328
Filing Date
2013-03-05
Accepted
2013-03-05 19:17:56
Documents
1
Period of Report
2013-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3288
  Complete submission text file 0001179110-13-004328.txt   4662
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
Actavis, Inc. (Issuer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
BUCHEN DAVID A (Reporting) CIK: 0001241751 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13305 | Film No.: 13667742